Research-Grade Sildenafil Analysis
Beligas Pharma Viagra represents a pharmaceutical-grade sildenafil citrate formulation designed for advanced phosphodiesterase enzyme research. This compound is a selective inhibitor of phosphodiesterase type 5 (PDE5), enabling researchers at Stroid UK Shop to investigate cyclic guanosine monophosphate signalling pathways in cardiovascular and smooth muscle tissue studies. Each tablet contains precisely measured 50mg sildenafil citrate, manufactured under pharmaceutical standards to ensure consistent research outcomes.
Laboratory Research Applications
Scientists examine sildenafil citrate’s mechanism of inhibiting PDE5 enzyme activity, which prevents degradation of cyclic GMP in vascular smooth muscle cells. Research laboratories investigate this compound’s effects on nitric oxide-mediated vasodilation pathways and endothelial function studies. Cardiovascular researchers analyse how PDE5 inhibition affects blood vessel relaxation and pulmonary arterial pressure in experimental models. Studies within our erection drugs category explore molecular interactions with guanylate cyclase enzymes and downstream signalling cascades. Researchers also evaluate sildenafil’s potential applications in pulmonary hypertension models and high-altitude physiology studies. Additional investigations examine the compound’s pharmacokinetic properties, including absorption rates, metabolic pathways, and elimination kinetics in various research protocols. Laboratory studies focus on dose-response relationships and temporal effects on cellular cyclic nucleotide levels. Scientists studying vascular biology utilise this compound to understand endothelial-dependent relaxation mechanisms and nitric oxide pathway modulation. Comparative studies with other phosphodiesterase inhibitors help researchers understand selectivity profiles and therapeutic indices. Advanced research programs investigate potential applications in metabolic disorders and cellular energy metabolism, complementing studies from our SARMs and peptides research divisions.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sildenafil Citrate |
| Dosage per Tablet | 50mg |
| Tablet Count | 50 tablets |
| Manufacturer | Beligas Pharma |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance Statement
This sildenafil citrate formulation is supplied exclusively for in-vitro laboratory research and analytical studies. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must maintain appropriate laboratory safety protocols and comply with institutional research guidelines when handling this compound. Storage recommendations include maintaining tablets in original packaging away from moisture and direct sunlight.
